The selective VEGFR inhibitor PTK787/ZK 222584 represses the activities of VEGFR-negative bone marrow-derived mesenchymal stem cells

Research output: Contribution to journalArticle

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)1249-1251
Number of pages3
JournalCancer Biology and Therapy
Volume8
Issue number13
Publication statusPublished - 2009 Jul 1

Keywords

  • Anti-tumor therapy
  • Mesenchymal stem cells
  • PDGF
  • PZK/ZK (Vatalanib)
  • VEGF
  • VEGFR inhibitor

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Molecular Medicine
  • Pharmacology

Cite this